Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program

Patients aged ≥ 70 years or older with an osteoporotic hip fracture treated with an
osteosynthesis or endoprosthesis will be included in this study.

The primary objective of the study is to assess the difference in the numbers of pre-defined
major adverse events (AE) which are related to the treatment, hospitalization and/or
immobilization between patients who were treated in a geriatric fracture center or in a usual
care center.

As a secondary objective, health economic implications and cost-effectiveness comparison
analyses will be performed.

In order to be able to analyze data based on the geographic regions as well as globally, in
each participating country, both a Geriatric Fracture Center (GFC) and a Usual Care Center
(UCC) will be included.

Preoperative Inclusion Criteria:

- Age ≥ 70 years

- Geriatric patients with hip fractures Treated either with oOsteosynthesis or
oEndoprosthesis

- Ability of the patient or assigned representative to understand the content of the
patient information / Informed Consent Form

- Signed and dated Institutional Review Board (IRB) / Ethics Committee (EC)-approved
written informed consent

Preoperative Exclusion Criteria:

- Recent history of substance abuse (ie, recreational drugs, alcohol) that would
preclude reliable assessment

- Prisoner

- Participation in any other medical device or medicinal product study within the
previous month that could influence the results of the present study